169 related articles for article (PubMed ID: 22132130)
1. Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.
Hadaczek P; Beyer J; Kells A; Narrow W; Bowers W; Federoff HJ; Forsayeth J; Bankiewicz KS
PLoS One; 2011; 6(11):e27728. PubMed ID: 22132130
[TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
[TBL] [Abstract][Full Text] [Related]
3. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Bartus RT; Brown L; Wilson A; Kruegel B; Siffert J; Johnson EM; Kordower JH; Herzog CD
Neurobiol Dis; 2011 Oct; 44(1):38-52. PubMed ID: 21704161
[TBL] [Abstract][Full Text] [Related]
4. Anterograde axonal transport of AAV2-GDNF in rat basal ganglia.
Ciesielska A; Mittermeyer G; Hadaczek P; Kells AP; Forsayeth J; Bankiewicz KS
Mol Ther; 2011 May; 19(5):922-7. PubMed ID: 21102559
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
6. Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector.
Manfredsson FP; Burger C; Rising AC; Zuobi-Hasona K; Sullivan LF; Lewin AS; Huang J; Piercefield E; Muzyczka N; Mandel RJ
Mol Ther; 2009 Nov; 17(11):1857-67. PubMed ID: 19707186
[TBL] [Abstract][Full Text] [Related]
7. Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain.
Kells AP; Forsayeth J; Bankiewicz KS
Neurobiol Dis; 2012 Nov; 48(2):228-35. PubMed ID: 22019719
[TBL] [Abstract][Full Text] [Related]
8. Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea.
Liu Y; Okada T; Shimazaki K; Sheykholeslami K; Nomoto T; Muramatsu S; Mizukami H; Kume A; Xiao S; Ichimura K; Ozawa K
Mol Ther; 2008 Mar; 16(3):474-80. PubMed ID: 18180779
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
Johnston LC; Eberling J; Pivirotto P; Hadaczek P; Federoff HJ; Forsayeth J; Bankiewicz KS
Hum Gene Ther; 2009 May; 20(5):497-510. PubMed ID: 19203243
[TBL] [Abstract][Full Text] [Related]
10. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
Peden CS; Burger C; Muzyczka N; Mandel RJ
J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
[TBL] [Abstract][Full Text] [Related]
11. Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.
Peden CS; Manfredsson FP; Reimsnider SK; Poirier AE; Burger C; Muzyczka N; Mandel RJ
Mol Ther; 2009 Mar; 17(3):524-37. PubMed ID: 19142181
[TBL] [Abstract][Full Text] [Related]
12. Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.
Drinkut A; Tereshchenko Y; Schulz JB; Bähr M; Kügler S
Mol Ther; 2012 Mar; 20(3):534-43. PubMed ID: 22086235
[TBL] [Abstract][Full Text] [Related]
13. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector.
Georgievska B; Jakobsson J; Persson E; Ericson C; Kirik D; Lundberg C
Hum Gene Ther; 2004 Oct; 15(10):934-44. PubMed ID: 15585109
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system.
Georgievska B; Kirik D; Björklund A
J Neurosci; 2004 Jul; 24(29):6437-45. PubMed ID: 15269253
[TBL] [Abstract][Full Text] [Related]
15. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease.
Du Y; Zhang X; Tao Q; Chen S; Le W
Neurodegener Dis; 2013; 11(3):113-28. PubMed ID: 22626907
[TBL] [Abstract][Full Text] [Related]
17. Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage.
Allocca M; Di Vicino U; Petrillo M; Carlomagno F; Domenici L; Auricchio A
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5199-206. PubMed ID: 17962474
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain.
Hadaczek P; Johnston L; Forsayeth J; Bankiewicz KS
Neuropharmacology; 2010 Jun; 58(7):1114-21. PubMed ID: 20153340
[TBL] [Abstract][Full Text] [Related]
19. Age and lesion-induced increases of GDNF transgene expression in brain following intracerebral injections of DNA nanoparticles.
Yurek DM; Hasselrot U; Cass WA; Sesenoglu-Laird O; Padegimas L; Cooper MJ
Neuroscience; 2015 Jan; 284():500-512. PubMed ID: 25453772
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.
Su X; Kells AP; Huang EJ; Lee HS; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Penticuff J; Eberling J; Federoff HJ; Forsayeth J; Bankiewicz KS
Hum Gene Ther; 2009 Dec; 20(12):1627-40. PubMed ID: 19671001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
